What Shapes the Way We Work

Clinical trials are complex, but the relationships behind them shouldn’t be.

True North was built around the idea that sponsors and research sites deserve a CRO that works alongside them — one that understands the pace, precision, and collaboration required to move ophthalmic research forward.

Our work is guided by deep ophthalmology expertise and a commitment to executing each study with precision, consistency, and accountability.
The true north difference

The Reasons we stand out

Exclusive Focus on Ophthalmology

Ophthalmology is not one of many therapeutic areas. It’s the only one.

This singular focus informs every part of our work, from protocol design and site selection to regulatory alignment and study execution. Our team understands the clinical nuances, operational realities, and evolving expectations that shape ophthalmic trials.

Specialization allows us to support studies with the insight and attention they require.

Accurate Scoping from the Start

Strong studies begin with thoughtful planning.

From the earliest conversations, we work closely with sponsors to define study timelines, budgets, and overall scope. Together, we review study assumptions, discuss potential challenges, and align on a path forward before the study begins. Shared planning minimizes unexpected change-order fees and supports smoother study execution.

When expectations are clear from the beginning, the focus stays on advancing the science.

Expert Protocol and Study Design

Well-designed protocols create the foundation for successful trials.

Our team brings deep ophthalmology expertise to protocol development, drawing on experience from both successful studies and those that revealed opportunities for improvement. This experience helps us identify design choices that support efficient execution and align with regulatory expectations.

By anticipating potential challenges early, we help position studies for smooth regulatory review and strong outcomes.

Low Team Turnover

Continuity strengthens collaboration.
The team assigned to your study stays with the project from beginning to end. This stability allows sponsors and research sites to work with people who know the details of the study, understand its goals, and remain closely connected as the trial progresses. Consistent teams support stronger partnerships, clearer communication, and seamless collaboration.

Rigorous Site Selection

Choosing the right sites matters.
Site selection is led by experts who know the ophthalmology research landscape and maintain close relationships with investigators and research sites. Potential sites are evaluated based on investigator experience, patient populations, and the operational capabilities needed to support your study. Several U.S. sites within our network can be activated rapidly, allowing studies to begin enrollment quickly when timelines are critical. Careful site selection positions studies for timely enrollment and successful execution.

Timely Communication

Communication stays clear and accessible.
Sponsors and research sites stay informed throughout the study with regular updates and open lines of communication when questions arise. We communicate directly so issues can be addressed quickly, and decisions can be made without unnecessary delay. Everyone understands where the study stands and what comes next.

Agility

Studies evolve. We adapt quickly.
When challenges arise, we work closely with sponsors and research sites to adjust plans, resolve logistical roadblocks, and keep studies progressing efficiently, all while maintaining the rigor required for high-quality clinical research. This flexibility maintains momentum.

Exclusive Focus on Ophthalmology

Ophthalmology is not one of many therapeutic areas. It’s the only one.

This singular focus informs every part of our work, from protocol design and site selection to regulatory alignment and study execution. Our team understands the clinical nuances, operational realities, and evolving expectations that shape ophthalmic trials.

Specialization allows us to support studies with the insight and attention they require.

Accurate Scoping from the Start

Strong studies begin with thoughtful planning.

From the earliest conversations, we work closely with sponsors to define study timelines, budgets, and overall scope. Together, we review study assumptions, discuss potential challenges, and align on a path forward before the study begins. Shared planning minimizes unexpected change-order fees and supports smoother study execution.

When expectations are clear from the beginning, the focus stays on advancing the science.

Expert Protocol and Study Design

Well-designed protocols create the foundation for successful trials.

Our team brings deep ophthalmology expertise to protocol development, drawing on experience from both successful studies and those that revealed opportunities for improvement. This experience helps us identify design choices that support efficient execution and align with regulatory expectations.

By anticipating potential challenges early, we help position studies for smooth regulatory review and strong outcomes.

Low Team Turnover

Continuity strengthens collaboration.
The team assigned to your study stays with the project from beginning to end. This stability allows sponsors and research sites to work with people who know the details of the study, understand its goals, and remain closely connected as the trial progresses. Consistent teams support stronger partnerships, clearer communication, and seamless collaboration.

Rigorous Site Selection

Choosing the right sites matters.
Site selection is led by experts who know the ophthalmology research landscape and maintain close relationships with investigators and research sites. Potential sites are evaluated based on investigator experience, patient populations, and the operational capabilities needed to support your study. Several U.S. sites within our network can be activated rapidly, allowing studies to begin enrollment quickly when timelines are critical. Careful site selection positions studies for timely enrollment and successful execution.

Timely Communication

Communication stays clear and accessible.
Sponsors and research sites stay informed throughout the study with regular updates and open lines of communication when questions arise. We communicate directly so issues can be addressed quickly, and decisions can be made without unnecessary delay. Everyone understands where the study stands and what comes next.

Agility

Studies evolve. We adapt quickly.
When challenges arise, we work closely with sponsors and research sites to adjust plans, resolve logistical roadblocks, and keep studies progressing efficiently, all while maintaining the rigor required for high-quality clinical research. This flexibility maintains momentum.

Exclusive Focus on Ophthalmology

Ophthalmology is not one of many therapeutic areas. It’s the only one.

This singular focus informs every part of our work, from protocol design and site selection to regulatory alignment and study execution. Our team understands the clinical nuances, operational realities, and evolving expectations that shape ophthalmic trials.

Specialization allows us to support studies with the insight and attention they require.

Accurate Scoping from the Start

Strong studies begin with thoughtful planning.

From the earliest conversations, we work closely with sponsors to define study timelines, budgets, and overall scope. Together, we review study assumptions, discuss potential challenges, and align on a path forward before the study begins. Shared planning minimizes unexpected change-order fees and supports smoother study execution.

When expectations are clear from the beginning, the focus stays on advancing the science.

Expert Protocol and Study Design

Well-designed protocols create the foundation for successful trials.

Our team brings deep ophthalmology expertise to protocol development, drawing on experience from both successful studies and those that revealed opportunities for improvement. This experience helps us identify design choices that support efficient execution and align with regulatory expectations.

By anticipating potential challenges early, we help position studies for smooth regulatory review and strong outcomes.

Low Team Turnover

Continuity strengthens collaboration.
The team assigned to your study stays with the project from beginning to end. This stability allows sponsors and research sites to work with people who know the details of the study, understand its goals, and remain closely connected as the trial progresses. Consistent teams support stronger partnerships, clearer communication, and seamless collaboration.

Rigorous Site Selection

Choosing the right sites matters.
Site selection is led by experts who know the ophthalmology research landscape and maintain close relationships with investigators and research sites. Potential sites are evaluated based on investigator experience, patient populations, and the operational capabilities needed to support your study. Several U.S. sites within our network can be activated rapidly, allowing studies to begin enrollment quickly when timelines are critical. Careful site selection positions studies for timely enrollment and successful execution.

Timely Communication

Communication stays clear and accessible.
Sponsors and research sites stay informed throughout the study with regular updates and open lines of communication when questions arise. We communicate directly so issues can be addressed quickly, and decisions can be made without unnecessary delay. Everyone understands where the study stands and what comes next.

Agility

Studies evolve. We adapt quickly.
When challenges arise, we work closely with sponsors and research sites to adjust plans, resolve logistical roadblocks, and keep studies progressing efficiently, all while maintaining the rigor required for high-quality clinical research. This flexibility maintains momentum.